Abstract Library

#4425 Ampullary composite gangliocytoma/neuroma and neuroendocrine tumour management

Introduction: Ampullary composite gangliocytoma/neuroma and neuroendocrine tumour (CoGNET), previously called ampullary gangliocytic paragangliomas (GP) are a rare entity, with only few reported cases in the literature.

Conference:

Presenting Author: Karam E

Authors: Karam E, Hollenbach M, Heise C, Abou Ali E, Gulla A,

Keywords: ampulla of Vater, gangliocytic paraganglioma, pancreaticoduodenectomy, transduodenal surgical ampullectomy, endoscopic papillectomy, composite gangliocytoma/neuroma neuroendocrine tumour, CoGNET,

#3942 A nomogram to preoperatively predict the aggressiveness of non-functional pancreatic neuroendocrine tumors based on CT features

Introduction: Most NF-pNETs are diagnosed incidentally, it’s a challenge for clinicians to choose between invasive management, which means oncologic resection, and conservative management. Preoperatively predicting the aggressiveness of NF-pNETs could guide clinicians to make individualized management decisions.

Conference:

Presenting Author: Shen X

Authors: Shen X, Jiang T, Mohammad Z, Wang X, Xie Z,

Keywords: aggressiveness, pancreatic neuroendocrine tumor, computed tomography, nomogram,

#3789 Comparison of postoperative textbook outcome between pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma – A nationwide retrospective cohort study

Introduction: Pancreatic neuroendocrine tumors (pNET) represent only 6% of pancreatic tumors, compared to 93% for pancreatic ductal adenocarcinoma (PDAC). Textbook outcome (TO) is a composite outcome measure that reflects a hospital’s surgical performance as well as quality of current practice.

Conference:

Presenting Author: Chen J

Authors: Chen J, Augustinus S, Engelsman A, Bonsing B, Groot Koerkamp B,

Keywords: pNET, PDAC, Dutch Pancreatic Cancer Audit, Textbook Outcome, Postoperative results,

#2820 Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma

Introduction: Esthesioneuroblastoma (ENB) is a rare malignancy with limited therapeutic options when unresectable or metastatic. The overexpression of cell-surface somatostatin receptors in ENB is a potential molecular target making it amenable to peptide receptor radionuclide therapy (PRRT). High-level evidence supporting PRRT has been published for unresectable gastroenteropancreatic neuroendocrine tumours; however, data is limited for PRRT efficacy for ENB.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Kamel Hasan O

Authors: Kamel Hasan O, Ravi Kumar A, Kong G, Grozinsky-Glasberg S, Hicks R,

Keywords: esthesioneuroblastoma, peptide receptor radionuclide therapy, lutetium-177 dotatate,

#1414 Non-functioning Adrenal Composite Pheochromocytoma-Ganglioneuroma Simultaneous with Subclinical Cushing's Syndrome Due to Contralateral Adrenal Hyperplasia - An Unusual Presentation

Introduction: “Composite” pheochromocytoma is a rare tumor, consisting of pheochromocytoma and neuroblastic tumors. The definite diagnosis is histological. Subclinical Cushing's syndrome refers to autonomous glucocorticoid production without specific signs and symptoms of Cushing's syndrome.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Kiraly A

Authors: Kiraly A, Muntean V, Domsa I, Ghervan C,

Keywords: adrenal, composite, pheochromocytoma, ganglioneuroma, hypercorticism.,